Area of research
Epidemiology · Clinical Psychology
Research interest
Research interests include Substance Abuse Treatment and Outcomes, Psychedelics and Drug Studies, Neurotransmitter Receptor Influence on Behavior, and Opioid Use Disorder Treatment.
Effects of cannabidiol in alcohol use disorder patients with and without co-occurring post-traumatic stress disorder: Tolerability but no evidence for efficacy in two randomized proof-of-concept trials.
The science of psychedelic medicine.
Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial
A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs.
Exploring the role of gender on treatment outcomes in older adults with alcohol use disorder.
Relief craving severity moderates nonpharmacological treatment outcomes in treatment-seeking older adults with alcohol use disorder.
Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.
The Therapeutic Effects of Classic Psychedelics in Alcohol Use Disorder
Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
Improvement in quality of life among women and men aged 60 years and older following treatment for alcohol use disorder.
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Stability of Posttreatment Reductions in World Health Organization (WHO) Drinking Risk Levels and Posttreatment Functioning in Older Adults with DSM-5 Alcohol Use Disorder: Secondary Data Analysis of the Elderly Study.
Evaluation of adding the community reinforcement approach to motivational enhancement therapy for adults aged 60 years and older with DSM-5 alcohol use disorder: a randomized controlled trial.
Gabapentin Enacarbil Extended‐Release Versus Placebo: A Likely Responder Reanalysis of a Randomized Clinical Trial
Gabapentin Enacarbil Extended-Release Versus Placebo: A Likely Responder Reanalysis of a Randomized Clinical Trial.
Brain activation and subjective anxiety during an anticipatory anxiety task is related to clinical outcome during prazosin treatment for alcohol use disorder.
The Alcohol Dependence Scale and DSM-5 alcohol use disorder: Severity ratings correspond insufficiently in older patients.
Stroop-related cerebellar and temporal activation is correlated with negative affect and alcohol use disorder severity.
Implementation of strength-based case management for opioid-dependent patients presenting in medical emergency departments: rationale and study design of a randomized trial.
Impact of comorbid mental disorders on outcomes of brief outpatient treatment for DSM-5 alcohol use disorder in older adults.
Benefit-cost analysis of SBIRT interventions for substance using patients in emergency departments
Classic hallucinogens in the treatment of addictions
Outpatient treatment of alcohol use disorders among subjects 60+ years: design of a randomized clinical trial conducted in three countries (Elderly Study)
Brief Intervention for Patients With Problematic Drug Use Presenting in Emergency Departments